Prevalence of asthma and allergic rhinitis among adults in Yaounde, Cameroon

Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults are lacking. We assessed the prevalence and determinants of asthma and allergic rhinitis in urban adult Cameroonians. A community-based survey was conducted from December 2013 to April 2014 among adults aged 19...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-04, Vol.10 (4), p.e0123099-e0123099
Hauptverfasser: Pefura-Yone, Eric Walter, Kengne, André Pascal, Balkissou, Adamou Dodo, Boulleys-Nana, Julie Raïcha, Efe-de-Melingui, Nelly Rachel, Ndjeutcheu-Moualeu, Patricia Ingrid, Mbele-Onana, Charles Lebon, Kenmegne-Noumsi, Elvira Christelle, Kolontchang-Yomi, Barbara Linda, Theubo-Kamgang, Boris Judicaël, Ebouki, Emilienne Régine, Djuikam-Kamga, Chrystelle Karen, Magne-Fotso, Christiane Gaelle, Amougou, Francine, Mboumtou, Liliane, Ngo-Yonga, Martine, Petchou-Talla, Elsie Linda, Afane-Ze, Emmanuel, Kuaban, Christopher
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults are lacking. We assessed the prevalence and determinants of asthma and allergic rhinitis in urban adult Cameroonians. A community-based survey was conducted from December 2013 to April 2014 among adults aged 19 years and above (N = 2,304, 57.3% women), selected through multilevel stratified random sampling across all districts of Yaounde (Capital city). Internationally validated questionnaires were used to investigate the presence of allergic diseases. Logistic regressions were employed to investigate the determinants of allergic conditions. Prevalence rates were 2.7% (95% CI: 2.1-3.4) for asthma-ever, 6.9% (5.9-7.9) for lifetime wheezing, 2.9% (92.2-3.6) for current wheezing and 11.4% (10.1-12.7) for self-reported lifetime allergic rhinitis; while 240 (10.4%) participants reported current symptoms of allergic rhinitis, and 125 (5.4%) had allergic rhino-conjunctivitis. The prevalence of current asthma medication use and self-reported asthma attack was 0.8 (0.4-1.2) and 1 (0.6-1.4) respectively. Multivariable adjusted determinants of current wheezing were signs of atopic eczema [2.91 (1.09-7.74)] and signs of allergic rhinitis [3.24 (1.83-5.71)]. Age group 31-40 years [0.27(0.09-0.78), p = 0.016] was an independent protective factor for wheezing. Determinants of current rhinitis symptoms were active smoking [2.20 (1.37-3.54), p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0123099